NEW YORK, Aug. 4, 2017 /PRNewswire/ -- Notice is hereby given that Monteverde & Associates PC has filed a class action lawsuit in the United States District Court for the Northern District of California, case no. 3:17-cv-04102, on behalf of shareholders of Jaguar Animal Health, Inc. ("Jaguar" or the "Company") (Nasdaq CM: JAGX) who held Jaguar securities and have been harmed by Jaguar's and its board of directors' alleged violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") in connection with the Company's acquisition of Napo Pharmaceuticals, Inc. (the "Proposed Merger").

Monteverde & Associates PC Logo

Under the terms of the merger agreement, Jaguar will assume (i) each outstanding and unexercised option to purchase Napo common stock, which will be converted into options to purchase Jaguar common stock, (ii) each outstanding warrant to purchase Napo common stock, which will be converted into warrants to purchase Jaguar common stock, and (iii) each outstanding restricted stock unit to acquire Napo common stock, which will be converted into restricted stock units to acquire Jaguar common stock. Jaguar shareholders before the Proposed Merger will experience dilution in the amount of approximately 75% as a result of the Proposed Merger.

The complaint alleges that the Proposed Merger is unfair to Jaguar shareholders and that the joint proxy statement/prospectus/information statement regarding the Proposed Merger (the "Proxy") provides materially incomplete and misleading information about the Company's and Napo's financials and the fairness of the Proposed Merger, in violation of Sections 14(a) and 20(a) of the Exchange Act.

If you wish to serve as lead plaintiff, you must move the Court no later than 60 days from today.  Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.  If you wish to discuss this action, or have any questions concerning this notice or your rights or interests, please contact Monteverde & Associates PC:

Click here for more information: www.monteverdelaw.com/investigations/m-a/ It is free and there is no cost or obligation to you.

Monteverde & Associates PC is a boutique class action securities and consumer litigation law firm that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing.  Monteverde & Associates PC lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave, Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com 
Tel: (212) 971-1341

Attorney Advertising. (C) 2017 Monteverde & Associates PC.  Prior results do not guarantee a similar outcome with respect to any future matter.

 

View original content with multimedia:http://www.prnewswire.com/news-releases/monteverde--associates-pc-files-class-action-lawsuit-on-behalf-of-shareholders-of-jaguar-animal-health-inc-in-the-northern-district-of-california-300500000.html

SOURCE Monteverde & Associates PC

Copyright 2017 PR Newswire

Jaguar Health (NASDAQ:JAGX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Jaguar Health Charts.
Jaguar Health (NASDAQ:JAGX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Jaguar Health Charts.